Works by Foster, Matthew C

Results: 28

Clinical and molecular features of FLT3 juxtamembrane domain missense mutations in acute myeloid leukaemia.

Published in:

Journal of Cellular & Molecular Medicine, 2022, v. 26, n. 24, p. 6079, doi. 10.1111/jcmm.17608

By:

Jensen, Christopher E.;
Montgomery, Nathan D.;
Galeotti, Jonathan;
Foster, Matthew C.;
Zeidner, Joshua F.

Publication type:

Article

A reappraisal of ASXL1 mutation sites and the cohesin-binding motif in myeloid disease.

Published in:

Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00876-w

By:

Johnson, Steven M.;
Haberberger, James;
Galeotti, Jonathan;
Ramkissoon, Lori;
Coombs, Catherine C.;
Richardson, Daniel R.;
Foster, Matthew C.;
Duncan, Daniel;
Zeidner, Joshua F.;
Ferguson, Naomi L.;
Montgomery, Nathan D.

Publication type:

Article

A reappraisal of ASXL1 mutation sites and the cohesin-binding motif in myeloid disease.

Published in:

2023

By:

Johnson, Steven M.;
Haberberger, James;
Galeotti, Jonathan;
Ramkissoon, Lori;
Coombs, Catherine C.;
Richardson, Daniel R.;
Foster, Matthew C.;
Duncan, Daniel;
Zeidner, Joshua F.;
Ferguson, Naomi L.;
Montgomery, Nathan D.

Publication type:

Letter

Comprehensive genomic profiling reveals molecular subsets of ASXL1-mutated myeloid neoplasms.

Published in:

Leukemia & Lymphoma, 2024, v. 65, n. 2, p. 209, doi. 10.1080/10428194.2023.2277672

By:

Johnson, Steven M.;
Haberberger, James;
Galeotti, Jonathan;
Ramkissoon, Lori;
Coombs, Catherine C.;
Richardson, Daniel R.;
Foster, Matthew C.;
Duncan, Daniel;
Montgomery, Nathan D.;
Ferguson, Naomi L.;
Zeidner, Joshua F.

Publication type:

Article

Clonal evolution of Philadelphia chromosome in acute myeloid leukemia after enasidenib treatment.

Published in:

2021

By:

Ramkissoon, Lori A.;
Buhlinger, Kaitlyn;
Nichols, Angela;
Coombs, Catherine C.;
Foster, Matthew C.;
Galeotti, Jonathan;
Kaiser-Rogers, Kathleen;
Richardson, Daniel R.;
Montgomery, Nathan D.;
Zeidner, Joshua F.

Publication type:

Letter

The utility of a telemedicine platform to monitor adherence and adverse effects of tyrosine kinase inhibitors.

Published in:

2019

By:

Copeland, Anureet C.;
Foster, Matthew C.;
Muluneh, Benyam;
Xenakis, James G.;
Ivanova, Anastasia;
Frankfurt, Olga;
Clayton, Monique;
Black, Anderson;
Rapchak, Barbara;
Wehbie, Robert S.

Publication type:

Letter

Clonal evolution of Philadelphia chromosome in acute myeloid leukemia after azacitidine treatment.

Published in:

2018

By:

Yogarajah, Meera;
Montgomery, Nathan;
Matson, Melissa;
Blanchard, Laura;
Frank, Cassiopeia;
Gallagher, Sean;
Pepin, Katherine;
Vaught, Lori;
Muluneh, Benyam;
Foster, Matthew C.;
Zeidner, Joshua F.

Publication type:

Case Study

Lenalidomide-associated hemolytic anemia.

Published in:

2015

By:

Lim, Ming Y.;
Raval, Jay S.;
Richards, Kristy L.;
Zeidner, Joshua F.;
Foster, Matthew C.

Publication type:

Case Study

The rapid enrollment design for Phase I clinical trials.

Published in:

2016

By:

Ivanova, Anastasia;
Wang, Yunfei;
Foster, Matthew C.

Publication type:

journal article

Cancer-related cognitive impairment in older adults with acute myeloid leukemia treated with hypomethylating agents and venetoclax chemotherapy: a longitudinal descriptive study.

Published in:

Supportive Care in Cancer, 2024, v. 32, n. 7, p. 1, doi. 10.1007/s00520-024-08673-2

By:

Chan, Ya-Ning;
Cho, Youngmin;
Hirschey, Rachel;
Piepmeier, Aaron;
Bender, Catherine M.;
Anderson, Ruth A.;
Foster, Matthew C.;
Bryant, Ashley Leak

Publication type:

Article

Genomic characteristics and prognostic significance of co‐mutated ASXL1/SRSF2 acute myeloid leukemia.

Published in:

American Journal of Hematology, 2021, v. 96, n. 4, p. 462, doi. 10.1002/ajh.26110

By:

Richardson, Daniel R.;
Swoboda, David M.;
Moore, Dominic T.;
Johnson, Steven M.;
Chan, Onyee;
Galeotti, Jonathan;
Esparza, Sonia;
Hussaini, Mohammad O.;
Van Deventer, Hendrick;
Foster, Matthew C.;
Coombs, Catherine C.;
Montgomery, Nathan D.;
Sallman, David A.;
Zeidner, Joshua F.

Publication type:

Article

A Comparison of Clofarabine-based (GCLAC) and Cladribine-based (CLAG) Salvage Chemotherapy for Relapsed/Refractory AML.

Published in:

2018

By:

Muluneh, Benyam;
Buhlinger, Kaitlyn;
Deal, Allison M.;
Zeidner, Joshua F.;
Foster, Matthew C.;
Jamieson, Katarzyna Joanna;
Bates, Jill;
Van Deventer, Hendrik W.

Publication type:

journal article

Complete Spontaneous Remission of Diffuse Large B-Cell Lymphoma of the Maxillary Sinus After Concurrent Infections.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2012, v. 12, n. 6, p. 455, doi. 10.1016/j.clml.2012.06.007

By:

Buckner, Tyler W.;
Dunphy, Cherie;
Fedoriw, Yuri D.;
van Deventer, Hendrik W.;
Foster, Matthew C.;
Richards, Kristy L.;
Park, Steven I.

Publication type:

Article

Hypomethylating agents super-responders: challenging the dogma of long-term remission for acute myeloid leukemia.

Published in:

2020

By:

Maakaron, Joseph E.;
Ozga, Michael P.;
Mannis, Gabriel N.;
Pulley, Will;
Foster, Matthew C.;
Zeidner, Joshua F.;
Mims, Alice S.

Publication type:

Case Study

Phase I Clinical Trials in Acute Myeloid Leukemia: 23-Year Experience From Cancer Therapy Evaluation Program of the National Cancer Institute.

Published in:

2016

By:

Zeidner, Joshua F.;
Karp, Judith E.;
Blackford, Amanda L.;
Foster, Matthew C.;
Dees, E. Claire;
Smith, Gary;
Ivy, S. Percy;
Harris, Pamela

Publication type:

journal article

Entospletinib with decitabine in acute myeloid leukemia with mutant TP53 or complex karyotype: A phase 2 substudy of the Beat AML Master Trial.

Published in:

Cancer (0008543X), 2023, v. 129, n. 15, p. 2308, doi. 10.1002/cncr.34780

By:

Duong, Vu H.;
Ruppert, Amy S.;
Mims, Alice S.;
Borate, Uma;
Stein, Eytan M.;
Baer, Maria R.;
Stock, Wendy;
Kovacsovics, Tibor;
Blum, William;
Arellano, Martha L.;
Schiller, Gary J.;
Olin, Rebecca L.;
Foran, James M.;
Litzow, Mark R.;
Lin, Tara L.;
Patel, Prapti A.;
Foster, Matthew C.;
Redner, Robert L.;
Al‐Mansour, Zeina;
Cogle, Christopher R.

Publication type:

Article

Evaluation and optimization of a clinical pharmacist driven transitions of care model for malignant hematology.

Published in:

Journal of Oncology Pharmacy Practice, 2021, v. 27, p. 283, doi. 10.1177/1078155220916516

By:

Wind, Lucas S;
Knight, Thomas G;
Auten, Jessica J;
Bates, Jill S;
Marucci, Leonardo;
Creedle, Crista J;
Foster, Matthew C;
Muluneh, Benyam

Publication type:

Article

Patient engagement in first cycle comprehensive chemotherapy consultation pharmacist services and impact on patient activation.

Published in:

Journal of Oncology Pharmacy Practice, 2019, v. 25, n. 4, p. 896, doi. 10.1177/1078155219832644

By:

Bates, Jill S;
Auten, Jessica;
Sketch, Margaret R;
Patel, Tejendra;
Clark, Stephen Michael;
Morgan, Katherine P;
Muluneh, Benyam;
McLaughlin, Jacqueline E;
Pinelli, Nicole R;
Foster, Matthew C;
Amerine, Lindsey

Publication type:

Article

Rapid enrollment design for finding the optimal dose in immunotherapy trials with ordered groups.

Published in:

Journal of Biopharmaceutical Statistics, 2019, v. 29, n. 4, p. 625, doi. 10.1080/10543406.2019.1633654

By:

Xue, Xiaoqiang;
Foster, Matthew C;
Ivanova, Anastasia

Publication type:

Article

Secondary AML Emerging After Therapy with Hypomethylating Agents: Outcomes, Prognostic Factors, and Treatment Options.

Published in:

Current Hematologic Malignancy Reports, 2021, v. 16, n. 1, p. 97, doi. 10.1007/s11899-021-00608-6

By:

Richardson, Daniel R.;
Green, Steven D.;
Foster, Matthew C.;
Zeidner, Joshua F.

Publication type:

Article

Venetoclax‐induced tumour lysis syndrome in acute myeloid leukaemia.

Published in:

British Journal of Haematology, 2020, v. 188, n. 1, p. 173, doi. 10.1111/bjh.16235

By:

Esparza, Sonia;
Muluneh, Benyam;
Galeotti, Jonathan;
Matson, Melissa;
Richardson, Daniel R.;
Montgomery, Nathan D.;
Coombs, Catherine C.;
Jamieson, Katarzyna;
Foster, Matthew C.;
Zeidner, Joshua F.

Publication type:

Article

A phase II trial of bendamustine in combination with rituximab in older patients with previously untreated diffuse large B-cell lymphoma.

Published in:

British Journal of Haematology, 2016, v. 175, n. 2, p. 281, doi. 10.1111/bjh.14232

By:

Park, Steven I.;
Grover, Natalie S.;
Olajide, Oludamilola;
Asch, Adam S.;
Wall, James G.;
Richards, Kristy L.;
Sobol, Anna L.;
Deal, Allison M.;
Ivanova, Anastasia;
Foster, Matthew C.;
Muss, Hyman B.;
Shea, Thomas C.

Publication type:

Article

The Limitations and Promise of Immunotherapy With Chimeric Antigen--Modified T Cells.

Published in:

Oncology (08909091), 2016, v. 30, n. 10, p. 889

By:

Ranganathan, Raghuveer;
Foster, Matthew C.

Publication type:

Article

The Effects of Exercise on Patient-Reported Outcomes and Performance-Based Physical Function in Adults With Acute Leukemia Undergoing Induction Therapy: Exercise and Quality of Life in Acute Leukemia (EQUAL).

Published in:

Integrative Cancer Therapies, 2018, v. 17, n. 2, p. 263, doi. 10.1177/1534735417699881

By:

Bryant, Ashley Leak;
Deal, Allison M.;
Battaglini, Claudio L.;
Phillips, Brett;
Pergolotti, Mackenzi;
Coffman, Erin;
Foster, Matthew C.;
Wood, William A.;
Bailey, Charlotte;
Hackney, Anthony C.;
Mayer, Deborah K.;
Muss, Hyman B.;
Reeve, Bryce B.

Publication type:

Article

Response to Tyrosine Kinase Inhibitors in Real-World Patients With Chronic Myeloid Leukemia.

Published in:

Annals of Pharmacotherapy, 2022, v. 56, n. 7, p. 753, doi. 10.1177/10600280211044160

By:

Szeto, Andy H.;
Bucci, Tyler;
Deal, Allison;
Zhu, Anqi;
Ahmad, Majd;
Cass, Amanda S.;
Sketch, Margaret R.;
Kemper, Ryan;
Zeidner, Joshua F.;
Foster, Matthew C.;
Muluneh, Benyam;
Crona, Daniel J.

Publication type:

Article

Diagnostic Complexities of Eosinophilia.

Published in:

Archives of Pathology & Laboratory Medicine, 2013, v. 137, n. 2, p. 259, doi. 10.5858/arpa.2011-0597-RA

By:

Montgomery, Nathan D.;
Dunphy, Cherie H.;
Mooberry, Micah;
Laramore, Andrew;
Foster, Matthew C.;
Park, Steven I.;
Fedoriw, Yuri D.

Publication type:

Article

Tritiation of the cannabinoid receptor antagonist SR144528 involving lithium aluminum tritide reduction; assessment of the kinetic isotope effect by <sup>3</sup>H-NMR.

Published in:

Journal of Labelled Compounds & Radiopharmaceuticals, 2005, v. 48, n. 8, p. 589, doi. 10.1002/jlcr.952

By:

Seltzman, Herbert H.;
Foster, Matthew C.;
Wyrick, Christopher D.;
Burgess, Jason P.;
Ivy Carroll, F.

Publication type:

Article

A phase I dose-escalation study of clofarabine in combination with fractionated gemtuzumab ozogamicin in patients with refractory or relapsed acute myeloid leukemia.

Published in:

Leukemia & Lymphoma, 2012, v. 53, n. 7, p. 1331, doi. 10.3109/10428194.2011.647313

By:

Foster, Matthew C.;
Amin, Chirag;
Voorhees, Peter M.;
van Deventer, Hendrik W.;
Richards, Kristy L.;
Ivanova, Anastasia;
Whitman, Jennifer;
Chiu, Wingkeung Michael;
Barr, Nathan D.;
Shea, Thomas

Publication type:

Article